The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two. Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a virus that already has killed more than 510,000 people in the U.S. and is mutating in increasingly worrisome ways. The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death.
Johnson & Johnson’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine
March 1, 2021